Classification of the Crystallization Behavior of Amorphous Active Pharmaceutical Ingredients in Aqueous Environments

被引：0
|
作者：
Bernard Van Eerdenbrugh
Shweta Raina
Yi-Ling Hsieh
Patrick Augustijns
Lynne S. Taylor
机构：
[1] Purdue University,Department of Industrial and Physical Pharmacy, College of Pharmacy
[2] KU Leuven,Drug Delivery and Disposition
[3] Formulation Sciences,undefined
[4] Allergan,undefined
[5] Inc.,undefined
来源：
Pharmaceutical Research | 2014年 / 31卷
关键词：
active pharmaceutical ingredient; amorphous; crystallization; polarized light microscopy; synchrotron radiation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：969 / 982
页数：13
相关论文
共 50 条
  • [21] Prequalification of active pharmaceutical ingredients
    WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2015, 992 : 37 - 37
  • [22] Prequalification of active pharmaceutical ingredients
    WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2013, 981 : 29 - 29
  • [23] Computational Insights into Kinetic Hindrance Affecting Crystallization of Stable Forms of Active Pharmaceutical Ingredients
    Abramov, Yuriy A.
    Zhang, Peiyu
    Zeng, Qiao
    Yang, Mingjun
    Liu, Yang
    Sekharan, Sivakumar
    CRYSTAL GROWTH & DESIGN, 2020, 20 (03) : 1512 - 1525
  • [24] ORGN 622-Crystallization technology applications for the process development of Active Pharmaceutical Ingredients
    Rose, Peter R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [25] Technoeconomic Optimization of Continuous Crystallization for Three Active Pharmaceutical Ingredients: Cyclosporine, Paracetamol, and Aliskiren
    Diab, Samir
    Gerogiorgis, Dimitrios, I
    INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2018, 57 (29) : 9489 - 9499
  • [26] Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage
    Edueng, Khadijah
    Mahlin, Denny
    Grasjo, Johan
    Nylander, Olivia
    Thakrani, Manish
    Bergstrom, Christel A. S.
    MOLECULES, 2019, 24 (15):
  • [27] Co-Crystallization and Characterization of Pharmaceutical Ingredients
    Herrmann, Michael
    Foerter-Barth, Ulrich
    Kroeber, Hartmut
    Kempa, Paul Bernd
    Juez-Lorenzo, Maria del Mar
    Doyle, Stephen
    PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION, 2009, 26 (03) : 151 - 156
  • [28] Active pharmaceutical ingredients/pharmaceutical fine chemicals in Spain
    Beaus, R
    CHIMICA OGGI-CHEMISTRY TODAY, 2005, 23 (05) : 15 - 16
  • [29] Manufacturing peptides as active pharmaceutical ingredients
    Zompra, Aikaterini A.
    Galanis, Athanassios S.
    Werbitzky, Oleg
    Albericio, Fernando
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (02) : 361 - 377
  • [30] The revival of cyclodextrins as active pharmaceutical ingredients
    Kfoury, Miriana
    Lichtfouse, Eric
    Fourmentin, Sophie
    ENVIRONMENTAL CHEMISTRY LETTERS, 2024, : 1 - 6
12345